Introduction Monotherapy with protease-inhibitors (MPI) could be an alternative to cART for HIV treatment. protein; LBP p=0.07), inflammation (IL-6 p=0.04) and low-level viremia (p=0.035). In a multivariate model, a higher level of CD14+ CD16?CD163+ cells and sCD14, and presence of…